Consistently, Kaplan–Meier analysis indicated that NSCLC patients with low ZNF674-AS1 levels had a shorter overall survival than those with high ZNF674-AS1 levels (P < 0.0001; Fig. 1c). Here, ZNF674 is linked to non-small cell lung carcinoma.